Stay updated on AAV Gene Therapy in CNGB3 Achromatopsia Clinical Trial
Sign up to get notified when there's something new on the AAV Gene Therapy in CNGB3 Achromatopsia Clinical Trial page.

Latest updates to the AAV Gene Therapy in CNGB3 Achromatopsia Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check24 days agoNo Change Detected
- Check32 days agoChange DetectedThe page has removed detailed information about a clinical trial for AGTC-401 related to achromatopsia, including study endpoints, inclusion and exclusion criteria, and specific age groups for participants. Additionally, the revision number has been updated from v2.14.4 to v2.15.0.SummaryDifference22%
- Check39 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check82 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check96 days agoChange DetectedThe page has removed references to Applied Genetic Technologies Corp and its association with Beacon Therapeutics, while adding a note about heavy traffic affecting NLM-NCBI services and providing contact information for assistance.SummaryDifference2%
- Check104 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.1%
Stay in the know with updates to AAV Gene Therapy in CNGB3 Achromatopsia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AAV Gene Therapy in CNGB3 Achromatopsia Clinical Trial page.